Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Julie Fotheringham"'
Autor:
Karen Yao, Susan Gagnon, Nahid Akhyani, Elizabeth Williams, Julie Fotheringham, Elliot Frohman, Olaf Stuve, Nancy Monson, Michael K Racke, Steven Jacobson
Publikováno v:
PLoS ONE, Vol 3, Iss 4, p e2028 (2008)
The alpha(4) integrin antagonist natalizumab was shown to be effective in patients with immune-mediated disorders but was unexpectedly associated with JC polyomavirus associated progressive multifocal leukoencephalopathy (PML) in two multiple scleros
Externí odkaz:
https://doaj.org/article/d375c61675a14e448828e19c8729731f
Autor:
Julie Fotheringham, Donatella Donati, Nahid Akhyani, Anna Fogdell-Hahn, Alexander Vortmeyer, John D Heiss, Elizabeth Williams, Steven Weinstein, Derek A Bruce, William D Gaillard, Susumu Sato, William H Theodore, Steven Jacobson
Publikováno v:
PLoS Medicine, Vol 4, Iss 5, p e180 (2007)
BackgroundHuman herpesvirus-6 (HHV-6) is a beta-herpesvirus with 90% seroprevalence that infects and establishes latency in the central nervous system. Two HHV-6 variants are known: HHV-6A and HHV-6B. Active infection or reactivation of HHV-6 in the
Externí odkaz:
https://doaj.org/article/b530a6faacc44845bf3a5e9098ba6b85
Autor:
Naomi Sengamalay, Nahid Akyani, Michael R. Bishop, Julie Fotheringham, Karen Yao, John Barrett, Steven Jacobson, Fatah Kashanchi, Elodie Ghedin, Donatella Donati
Publikováno v:
Journal of Clinical Virology
Background: HHV-6 has been implicated in a number of neurological disorders. Recent evidence has suggested high incidence of HHV-6 infection in patients (46%) undergoing allogeneic bone marrow transplant (BMT). Objective: To investigate whether HHV-6
Autor:
Karen Yao, Jenny Ahlqvist, Nahid Akhyani, Anna Fogdell-Hahn, Julie Fotheringham, Steven Jacobson
Publikováno v:
Journal of Neurovirology
Human herpesvirus 6 (HHV-6) is a ubiquitous beta -herpesvirus associated with a number of clinical disorders. Two closely but biologically distinct variants have been described. HHV-6 variant B causes the common childhood disease exhanthem subitum, a
Autor:
Julie Fotheringham, Grant M. Hatch, Fred Y. Xu, Elissavet Kardami, Mona Nemer, Patrick C. Choy
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1485:1-10
We examined if elevation in lysophosphatidylethanolamine acyltransferase activity was associated with elevation in phosphatidylethanolamine content during differentiation of P19 teratocarcinoma cells into cardiac myocytes. P19 cells were induced to u
Publikováno v:
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 3(2)
Human herpesvirus 6 (HHV-6) infects and establishes latency in the central nervous system (CNS). Reactivation of latent HHV-6 has been associated with neurologic diseases including epilepsy and multiple sclerosis (MS). In vivo, HHV-6 has been localiz
Autor:
Steven Jacobson, Nahid Akhyani, John D. Heiss, Elizabeth Williams, Anna Fogdell-Hahn, Julie Fotheringham, Steven L. Weinstein, William D. Gaillard, William H. Theodore, Susumu Sato, Alexander O. Vortmeyer, Derek Andrew Bruce, Donatella Donati
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 4, Iss 5, p e180 (2007)
PLoS Medicine, Vol 4, Iss 5, p e180 (2007)
Background Human herpesvirus-6 (HHV-6) is a β-herpesvirus with 90% seroprevalence that infects and establishes latency in the central nervous system. Two HHV-6 variants are known: HHV-6A and HHV-6B. Active infection or reactivation of HHV-6 in the b
Publikováno v:
Journal of neurovirology. 12(4)
The beta-herpesvirus human herpesvirus-6 (HHV-6) is becoming increasingly recognized as an important pathogen in immunocompromised patients, particularly in post bone marrow transplant (BMT). Reactivation of latent HHV-6 resulting in encephalitis has
Autor:
Steven Jacobson, Unsong Oh, Alexander O. Vortmeyer, Nahid Akhyani, Elizabeth Williams, Donatella Donati, Julie Fotheringham, Michael R. Bishop, John Barrett, Juan Gea-Banacloche
Publikováno v:
The Journal of infectious diseases. 195(3)
One-half of bone-marrow transplant (BMT) and stem-cell transplant recipients have reactivation of latent human herpesvirus (HHV)-6 2-4 weeks after transplant. Although the detection of viral DNA, RNA, and antigen in brain material confirmed active HH